The Enterprise Value as of June 2026 (TTM) for Palvella Therapeutics, Inc. (PVLA) is 1.08B

According to Palvella Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.08B. This represents a change of 27.89% compared to the average of 846.22M of the last 4 quarters.

Palvella Therapeutics, Inc. (PVLA) Historical Enterprise Value (quarterly & annually)

How has PVLA Enterprise Value performed in the past?

The mean historical Enterprise Value of Palvella Therapeutics, Inc. over the last ten years is 155.79M. The current 1.08B Enterprise Value has changed 69.36% with respect to the historical average. Over the past ten years (40 quarters), PVLA's Enterprise Value was at its highest in in the March 2026 quarter at 1.43B. The Enterprise Value was at its lowest in in the December 2024 quarter at -56890792.00.

Palvella Therapeutics, Inc. (PVLA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Palvella Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Palvella Therapeutics, Inc. (PVLA) Average Enterprise Value

How has PVLA Enterprise Value performed in the past?

The current Enterprise Value of Palvella Therapeutics, Inc. (PVLA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Palvella Therapeutics, Inc. (PVLA) Enterprise Value vs. Peers

How is PVLA’s Enterprise Value compared to its peers?

Palvella Therapeutics, Inc.’s Enterprise Value is less than GH Research PLC (1.21B), greater than ARS Pharmaceuticals, Inc. (1.04B), less than Nanobiotix S.A. (1.60B), less than ProKidney Corp. (1.15B), greater than Savara Inc. (1.07B), greater than Kura Oncology, Inc. (788.60M), greater than Arbutus Biopharma Corporation (818.44M), greater than Rezolute, Inc. (375.04M), greater than EyePoint Pharmaceuticals, Inc. (1.03B), less than Tyra Biosciences, Inc. (1.53B),

Build a custom stock screener for Palvella Therapeutics, Inc. (PVLA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Palvella Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Palvella Therapeutics, Inc. (PVLA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Palvella Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.